Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03944434
Title FACILE: FeAsibility of First-line riboCIclib in oLdEr Patients With Advanced Breast Cancer (FACILE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Sandro Pitigliani
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole + Ribociclib

Letrozole + Ribociclib

Leuprolide

Goserelin

Triptorelin

Age Groups: senior
Covered Countries ITA

Facility Status City State Zip Country Details
Hospital of Prato Recruiting Prato Please Select: 59100 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field